Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share (CHRO)

Q: What does CUSIP 171126105 represent in this 13F holders report?

CUSIP 171126105 is the security identifier for CHRO - Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held CHRO - Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share in Q3 2025?

No institutional holders were reported for CHRO - Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share in Q3 2025; review adjacent reporting periods for trend context.

CUSIP: 171126105

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 6,039,027
Total 13F shares: 0
Share change: -147,903
Total reported value: $0
Price per share: $1.26
Number of holders: 0
Value change: -$187,297
Number of sells: 5

Quarterly Holders Quick Answers

What is CUSIP 171126105?
CUSIP 171126105 identifies CHRO - Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q2 2025

Recent filing periods for CUSIP 171126105:

Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share (CHRO)

Q3 2025 13F Holders as of 30 Sep 2025

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of CHRO - Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share as of Q3 2025.